P2Y12 inhibitors: all 610 studies that test it
Page 7 of 7. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.
- The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)CompletedNCT00189618Phase 4
- CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial DiseaseCompletedNCT00174759Phase 3
- Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With ClopidogrelCompletedNCT00163267Phase 2/3
- 75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)CompletedNCT00140465Phase 4
- Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)CompletedNCT00115375Phase 2
- A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial HypertensionCompletedNCT00105209Phase 2
- Pharmacokinetics/Pharmacodynamics (PK/PD) of CangrelorCompletedNCT00102674Phase 1
- Secondary Prevention of Small Subcortical Strokes TrialCompletedNCT00059306Phase 3
- Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)CompletedNCT00050817Phase 3
- The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3AStatus unknownNCT00004564Not applicable